United States · FDA National Drug Code directory
Glimepiride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-7406_e372bb60-62d3-432c-ae33-9343c84be191
- Product NDC
- 50090-7406
- Form
- TABLET
- Composition / generic term
- Glimepiride
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230731
- Source listing expiry
- 20261231
Source-listed ingredients
- GLIMEPIRIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (50090-7406-0) · 50090-7406-0
- 100 TABLET in 1 BOTTLE (50090-7406-1) · 50090-7406-1
- 60 TABLET in 1 BOTTLE (50090-7406-2) · 50090-7406-2
- 90 TABLET in 1 BOTTLE (50090-7406-3) · 50090-7406-3
- 180 TABLET in 1 BOTTLE (50090-7406-4) · 50090-7406-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →